Søren Jensby Nielsen

机构：Amgen (United States), Amgen (Switzerland) · ORCID：0009-0004-7115-5189

发表论文 84 篇 · 总被引 8626 次 · h-index 37

代表论文

• Assessing sample and miRNA profile quality in serum and plasma or other biofluids (2012 · Methods · 被引 698)
• An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity (2010 · Cancer Research · 被引 171)
• Emerging classes of protein–protein interaction inhibitors and new tools for their development (2004 · Current Opinion in Chemical Biology · 被引 166)
• Anticancer agent CHS-828 inhibits cellular synthesis of NAD (2008 · Biochemical and Biophysical Research Communications · 被引 120)
• AP214, an analogue of α-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality (2008 · Kidney International · 被引 110)
• C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer (2015 · Oncotarget · 被引 89)